Using cancer microarray clinical trials, we addressed the following questions: Do trials which share their microarray data receive more citations?
The microarray data have been submitted to the GEO and received the accession number GSE17320.
The SLA/PrV and the Qiagen-NRSP8 microarray data have been submitted to the GEO and received accession numbers GSE8676 and GSE9259, respectively.
Microarray data have been uploaded to the NCBI GEO microarray repository.
Therefore, how to combine the promoter analysis with the microarray data has received considerable interest.
Computers interpret the data received.
In contrast, CREB1 and ATF-4 are the top-scoring transcriptional regulators with respect to microarray data but they do not receive any score based on the iTRAQ data.
The microarray data were submitted to the GEO and received the accession number GSE59263.
Multivariate linear regression was used to evaluate the association between the public availability of a trial's microarray data and number of citations (after log transformation) it received.
When attempting to interpret the ensuing microarray data, therefore, we could be confident that the cells received functional doses of both molecules.
